Stem Cell Therapy for Spinal Cord

What causes spinal cord injury?

SCI results from either a traumatic event or an underlying disease process. Which category applies affects both prognosis and whether a regenerative approach is even relevant.

Traumatic causes:

• Motor vehicle accidents — the leading cause globally
• Falls, especially in older adults
• Acts of violence (gunshot or stab wounds)
• Sports and recreational injuries, including diving into shallow water
• Sudden, forceful spinal twisting or impact
• Electrocution

Non-traumatic causes:

• Spinal or metastatic tumors compressing the cord
• Arthritis-related spinal stenosis (canal narrowing)
• Infections such as epidural abscess or osteomyelitis
• Myelitis (inflammation of the spinal cord)
• Degenerative disc disease
• Congenital conditions such as spina bifida
• Syringomyelia (fluid-filled cysts within the cord)
• Ischemia (reduced blood flow to the cord)

Why the cause and level matter for treatment planning

Injury level (cervical, thoracic, or lumbar) and completeness together determine the extent of functional loss — higher and more complete injuries generally mean more widespread impairment. A traumatic cervical injury and a slow-developing non-traumatic thoracic compression from a tumor are managed on very different timelines, and the tumor-related case requires oncologic treatment first, not a regenerative therapy discussion. Our oncology-adjacent teams can advise separately where a tumor is the underlying cause.

Continue to Symptoms to see what to watch for, or Diagnosis to see how level and completeness are actually confirmed.

What are the symptoms of spinal cord injury?

Symptoms vary by injury level and completeness, but commonly include:

• Weakness or paralysis below the injury level
• Numbness or tingling sensations
• Loss of bowel or bladder control
• Pain or discomfort at or below the injury site
• Spasticity (muscle stiffness or spasms)
• Difficulty breathing (more common with higher, cervical injuries)
• Problems with balance and walking
• Changes in sexual function

Emergency symptoms — seek immediate care

Suspected spinal cord injury is a medical emergency. Seek immediate care if you notice:

• Severe back or neck pain following an injury
• Sudden weakness or loss of control in any limb
• Numbness or loss of sensation
• Loss of bladder or bowel control
• Difficulty with balance, walking, or breathing
• A visibly twisted neck or back after trauma

Important: Symptoms don’t always appear immediately — numbness or paralysis can develop gradually. Any head or neck trauma should be treated as a possible spinal injury until a medical professional confirms otherwise. Early evaluation directly affects how much secondary damage can be limited — this is the clinical rationale behind time-sensitive treatment decisions.

How is spinal cord injury diagnosed?

The completeness of the injury (assessed via the ASIA Impairment Scale, referenced later under Treatment Results) is the single most important diagnostic output for anyone exploring regenerative options — it is what most existing stem cell research studies use to define and compare patient groups.

If you already have recent MRI and neurological assessment reports, you can upload them for a free specialist review rather than repeating imaging unnecessarily.

Stem Cell Treatment for Spinal Cord Injury in India

Spinal cord injury (SCI) often causes permanent neurological impairment, and conventional care — surgery and rehabilitation — provides limited recovery beyond stabilization. Stem cell therapy is being researched as a complementary approach aimed at supporting nerve repair, delivered at our accredited New Delhi facility alongside standard rehabilitation, not instead of it.

How stem cells may help

• Cell replacement — differentiating into neurons and glial cells to potentially replace lost cells
• Regeneration support — encouraging new connections between nerve cells (axonal sprouting)
• Immune modulation — reducing inflammation to create a more favorable healing environment
• Angiogenesis — supporting new blood vessel growth to improve blood flow to the injury site
• Trophic support — secreting growth factors that nourish and protect surviving nerve cells

Types of stem cells under investigation

Note: Viezec does not use embryonic or fetal cells in any protocol (see Treatment Disclaimer).

Multiple clinical trials are investigating stem cell therapy for SCI, and while some report meaningful recovery, no universally accepted breakthrough exists yet. One 2023 study noted measurable neurological improvement in participants but emphasized the difficulty of definitively separating treatment effect from natural recovery — a limitation worth understanding before enrolling in any program.

Where to get treatment and what it costs

Reputable centers in India, including Viezec’s New Delhi facility, offer this therapy with personalized treatment planning. See Cost below for a full country-by-country comparison, and Delivery Method for how cells actually reach the injury site.

How Are Stem Cells Delivered for Spinal Cord Injury?

The delivery method chosen affects how many cells reach the injury site and how invasive the procedure is. Four approaches are currently used or under investigation:

What determines the right method for a given patient

• Stem cell type used — different cells have different delivery requirements
• Timing — how soon after injury treatment begins
• Injury severity and location — more severe or localized injuries may need more targeted (and invasive) delivery

Your specialist selects the delivery method as part of your individualized treatment protocol after reviewing your MRI and neurological assessment.

What Improvements Are Reported After Stem Cell Therapy for Spinal Cord Injury?

Stem cell therapy is researched as a way to support tissue repair through several mechanisms rather than reversing established tissue loss outright:

• Tissue repair and replacement — differentiation into neurons and glial cells that may replace damaged tissue
• Inflammation modulation — reduced expression of inflammatory genes, increased neuroprotective gene expression
• Angiogenesis — new blood vessel formation supporting tissue repair
• Neurotrophic effects — growth factors supporting survival of existing neurons
• Axon regeneration and remyelination — supporting restored nerve signal transmission

Reported outcome areas

What to weigh before proceeding

• Early research phase — larger, long-term controlled trials are still needed
• Variable outcomes — recovery depends on injury severity, cell type, timing, and individual response
• Safety monitoring required — throughout and after treatment
• Best used as one part of a combined plan — alongside rehabilitation, and where relevant, epidural stimulation, physiotherapy, or other supportive therapies
• Realistic expectations matter — this is a potential-improvement therapy, not a guaranteed cure

How Does Stem Cell Therapy Work for Spinal Cord Injury?

• Cell replacement — differentiation into neurons, astrocytes, and oligodendrocytes to potentially restore damaged neural pathways
• Neuroprotection — secreted factors that protect existing neurons from further damage
• Axonal regeneration and remyelination — supporting damaged axon growth and nerve fiber remyelination
• Immunomodulation — MSCs in particular secrete anti-inflammatory cytokines (IL-10, TGF-β) that reduce the excessive inflammatory response that otherwise hinders healing
• Angiogenesis — stimulating new blood vessel formation to improve blood supply to the injury site
• Glial scar modulation — secreted factors that may modify the inhibitory environment created by glial scarring, supporting better axonal regeneration

Our Promise

Viezec is committed to transparent, evidence-based regenerative medicine — not overstated outcome promises. In practice:

• No cure claims. Stem cell therapy for spinal cord injury is offered as a researched, supportive option — never marketed as a guaranteed reversal of paralysis or nerve damage.
• Injury classification before treatment. No protocol is proposed without confirming injury level and completeness (see Diagnosis).
• Regulatory transparency. Stem cell interventions beyond approved uses are investigational under Indian guidelines and offered only within regulated research settings, as stated in your own Ethical & Transparent Patient Guidance box further down this page — worth repeating briefly here too, since “Our Promise” is a natural place a skeptical reader checks this claim.
• Accredited facilities. NABH accreditation and NABL accreditation.
• No embryonic or fetal cells used — stated explicitly in your Treatment Disclaimer; worth repeating here since this section is where many readers form their trust judgment first.
• International patient support — visa assistance, accommodation coordination, and structured post-treatment follow-up.

Read more about our approach in India →

Treatment Results

Stem cell therapy for SCI remains in early-stage clinical translation, but existing studies and patient reports offer some specific, sourced findings worth presenting precisely rather than in vague terms:

Neurological function

• Sensory improvements: reported in an estimated 50–60% of patients across pooled clinical reports; one study using the HuCNS-SC cell line found reliable sensory gains in 5 of 12 patients, and another trial reported 96% of participants regaining at least one level of neurological function.
• Motor function: less consistent evidence than for sensory function — some studies report improved motor scores, particularly in incomplete injuries, but a meta-analysis combining multiple studies found no significant motor-score improvement over standard rehabilitation alone. (Stating this plainly, rather than only citing the positive figures, is what separates a trustworthy medical page from a marketing page — keep this contrast intact.)
• Overall injury severity (ASIA/AIS grading): a meta-analysis found a notable reduction in overall SCI severity as measured by this scale.

Autonomic function

• Bladder control — reduced residual urine volume and improved sensation/function reported
• Gastrointestinal function — improved defecation sensation and control in some studies
• Other autonomic function — improvements in sexual function, spasticity, and pain reported by some patients

Key limitations to state plainly

• Most studies involve small sample sizes and often lack robust control groups
• Immune rejection, infection, and (rarely) tumor formation are documented risks, particularly with ESCs and iPSCs
• Treatment appears more effective when administered early — ideally within a few weeks of injury
• Combining stem cell therapy with rehabilitation, biomaterial scaffolds, or growth factors may improve outcomes over stem cell therapy alone

Testimonials

Rajesh K. – Delhi, India – February 2020 – ⭐⭐⭐⭐☆
“After my spinal cord injury, I lost hope of walking. Viezec’s stem cell therapy gave me partial movement back and reduced chronic pain.”

Linda P. – Boston, USA – August 2020 – ⭐⭐⭐⭐⭐
“I regained strength in my legs after treatment. Viezec’s care made my recovery smoother and gave me confidence to live more independently.”

Ahmed N. – Cairo, Egypt – January 2021 – ⭐⭐⭐⭐☆
“My spinal injury left me with numbness. Post stem cell therapy at Viezec, sensations gradually returned, and my daily mobility improved.”

Sophie M. – London, UK – June 2021 – ⭐⭐⭐⭐⭐
“The doctors at Viezec guided me throughout the process. After treatment, my muscle control improved, and I can now sit longer without discomfort.”

Carlos R. – Madrid, Spain – March 2022 – ⭐⭐⭐⭐☆
“Stem cell therapy reduced my dependency on mobility aids. I now feel stronger, and physiotherapy works much better after the treatment.”

Aisha H. – Dubai, UAE – October 2022 – ⭐⭐⭐⭐⭐
“My husband’s injury limited his daily life. Thanks to Viezec, he regained partial leg function and his pain levels decreased significantly.”

James L. – Toronto, Canada – April 2023 – ⭐⭐⭐⭐☆
“I was wheelchair-bound for years. After Viezec’s therapy, I can stand with support, and my recovery continues positively.”

Fatima S. – Riyadh, Saudi Arabia – September 2023 – ⭐⭐⭐⭐⭐
“The treatment improved my ability to move and reduced spasms. Viezec’s professional care gave me both results and hope.”

Daniel K. – Sydney, Australia – January 2024 – ⭐⭐⭐⭐☆
“I noticed gradual improvements in sensation and strength after therapy. Viezec’s stem cell program is truly life-changing.”

Elena G. – Rome, Italy – May 2025 – ⭐⭐⭐⭐⭐
“Viezec’s therapy helped me recover movements I thought I had lost forever. My independence has improved, and so has my confidence.”

Treatment Disclaimer

Stem cell therapy for spinal cord injury is experimental and may not work for every patient. Treatment may be declined, or the proposed protocol may change, depending on individual health status at the time of evaluation.

Viezec Stem Cell Institute aims to provide the best available, globally validated technology and safety standards. As with any medical treatment, no guarantees or cure claims are made regarding the extent of response. Results vary between patients, even with similar diagnoses, and no certainty of outcome can be offered, inferred, or suggested. Viezec does not use embryonic or fetal cells in any treatment.